CLAIRE HERBERT: Open Payments
NPI 1356836563 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 38 payments from 12 companies in 2025. Trend: 2023 $2,129 · 2024 $771 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $295 |
| Alkermes, Inc. | 7 | $278 |
| ABBVIE INC. | 12 | $139 |
| E.R. Squibb & Sons, L.L.C. | 3 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Indivior Inc. | 1 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Braeburn Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: Auvelity, LYBALVI, VRAYLAR, COBENFY, ABILIFY ASIMTUFII, ARISTADA, SUBLOCADE, INGREZZA.
Industry payments across OH — which companies pay providers there.
